Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/12/24 → 1/12/26 |
Funding
- Rho Incorporated: $30,784.00
A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease
- Slevin, John (PI)
| Status | Active |
|---|---|
| Effective start/end date | 1/12/24 → 1/12/26 |